Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.

Telomerase activity was measured with a quantitative assay, based on a modification of telomeric repeat amplification protocol method, in bladder cancers and apparently normal mucosa in 33 patients. In the same patients, the enzyme was also measured in exfoliated cells collected both with voided urine and bladder washings. Results obtained in urine were compared with those from 20 healthy subjects. Telomerase activity was present in 31 (94%) bladder cancer tissues and in 23 (72%) apparently normal mucosa samples. However, the levels of enzyme activity were significantly higher in cancer tissues in comparison with normal mucosa (mean +/- SD, 47.3 +/- 23.2 and 14.9 +/- 6.1 ng DNA/microg protein, respectively; P < 0.0001). Telomerase activity in bladder cancer tissues was not related to tumor stage and grade. Enzyme activity was present in 27 urine samples and in 27 (82%) bladder washings collected from cancer patients. We did not find correlation between the activity in urine and washings, and their mean levels were not different (22.2 +/- 10.1 and 20.7 +/- 8.0, respectively). Telomerase activity in bladder cancer tissues was correlated to its activity in urine (r = 0.650, P < 0.001) and in bladder washings (r = 0.410, P < 0.05). Only 2 of 20 urine samples from control subjects were found to express telomerase activity at a very low level. This was the first attempt to correlate telomerase activity in exfoliated cells from urine and bladder washings with the activity in corresponding bladder cancers. According to these results we postulate that telomerase activity in urine sediment reflects the activity in bladder cancers better than bladder washings and, for its easy collection, is to be preferred as diagnostic marker in this tumor.

[1]  B. Liu,et al.  Telomerase in human bladder cancer. , 2000, The Urologic clinics of North America.

[2]  K. Ohyashiki,et al.  Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection. , 1999, International journal of oncology.

[3]  B. Liu,et al.  Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. , 1999, Urology.

[4]  N. Oakley Urinary cytology and competitive reverse transcriptase polymerase chain reaction analysis of a specific CD44 variant to detect and monitor bladder cancer , 1999 .

[5]  M. Rahat,et al.  Telomerase activity in patients with transitional cell carcinoma , 1999, Cancer.

[6]  D J O'Kane,et al.  Comparison of screening methods in the detection of bladder cancer. , 1999, The Journal of urology.

[7]  K. Ohyashiki,et al.  A combination of semiquantative telomerase assay and in‐cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia , 1998, Cancer.

[8]  S. Kyo,et al.  Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  S. Kagawa,et al.  Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. , 1998, British journal of urology.

[10]  S. Capaccioli,et al.  Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. , 1998, Clinical chemistry.

[11]  M. Droller,et al.  Urinary telomerase and its possible role as a marker for bladder cancer. , 1998, The Keio journal of medicine.

[12]  J. Shay,et al.  Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  F. Carballo,et al.  Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique. , 1998, Clinical chemistry.

[14]  K. Yamaguchi,et al.  Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism. , 1998, International journal of cancer.

[15]  S. C. Yang,et al.  Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  M. Droller,et al.  Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity , 1998, Cancer.

[17]  W. Murphy,et al.  The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. , 1997, The Journal of urology.

[18]  C. Cordon-Cardo,et al.  Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  O. Yoshida,et al.  Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. , 1997, Journal of the National Cancer Institute.

[20]  A. Gazdar,et al.  Telomerase and early detection of cancer: a National Cancer Institute workshop. , 1997, Journal of the National Cancer Institute.

[21]  R. Dahse,et al.  Telomeres and telomerase: biological and clinical importance. , 1997, Clinical chemistry.

[22]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[23]  N. Kim,et al.  Clinical implications of telomerase in cancer. , 1997, European journal of cancer.

[24]  J. Double,et al.  Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. , 1997, British Journal of Cancer.

[25]  Kazuhiro Yoshida,et al.  Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine , 1997, Cancer.

[26]  F. Ishikawa,et al.  A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. , 1996, Oncogene.

[27]  José Costa,et al.  PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR , 1996, Nucleic Acids Res..

[28]  M. Mandal,et al.  Cell cycle-dependent modulation of telomerase activity in tumor cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Hosaka,et al.  Telomerase activity in human bladder cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  K. Collins,et al.  Structure and function of telomerase. , 1996, Current opinion in cell biology.

[31]  G. Morin Is telomerase a universal cancer target? , 1995, Journal of the National Cancer Institute.

[32]  A. Gazdar,et al.  Telomerase activity in small-cell and non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.

[33]  M. S. Rhyu Telomeres, telomerase, and immortality. , 1995, Journal of the National Cancer Institute.

[34]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[35]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[36]  S. Raab,et al.  Low grade transitional cell carcinoma of the bladder. Cytologic Diagnosis by Key Features as Identified by Logistic Regression Analysis , 1994, Cancer.

[37]  E. Blackburn Telomeres: No end in sight , 1994, Cell.

[38]  E. Blackburn,et al.  Structure and function of telomeres , 1991, Nature.

[39]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Murphy,et al.  Evaluation of biological markers in bladder cancer. , 1975, The Journal of urology.

[41]  G. Arnaldi,et al.  Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. , 2000, The Journal of clinical endocrinology and metabolism.

[42]  J. Campbell Financing the Ideal Long-Term Care System Through Social Insurance , 1999 .

[43]  H. Stein,et al.  Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. , 1998, The Journal of pathology.